Informações:
Falhas:
ID
31555
Descrição
Ketoconazole, Dexamethasone, and Hydrocortisone in Treating Patients With Prostate Cancer That Did Not Respond to Androgen-Deprivation Therapy; ODM derived from: https://clinicaltrials.gov/show/NCT00559481
Link
https://clinicaltrials.gov/show/NCT00559481
Palavras-chave
Versões (1)
- 03/09/2018 03/09/2018 -
Titular dos direitos
See clinicaltrials.gov
Transferido a
3 de setembro de 2018
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Prostate Cancer NCT00559481
Eligibility Prostate Cancer NCT00559481
- StudyEvent: Eligibility
Similar models
Eligibility Prostate Cancer NCT00559481
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Prostate carcinoma
Item
confirmed diagnosis of prostate cancer
boolean
C0600139 (UMLS CUI [1])
Antiandrogen therapy failed
Item
must have failed standard androgen-deprivation therapy
boolean
C0279492 (UMLS CUI [1,1])
C0231175 (UMLS CUI [1,2])
C0231175 (UMLS CUI [1,2])
Raised prostate specific antigen
Item
evidence of rising psa
boolean
C0178415 (UMLS CUI [1])
Client Characteristics
Item
patient characteristics:
boolean
C0815172 (UMLS CUI [1])
ECOG performance status
Item
ecog performance status 0-2
boolean
C1520224 (UMLS CUI [1])
Creatinine measurement, serum
Item
creatinine ≤ 2.0 mg/dl
boolean
C0201976 (UMLS CUI [1])
Aspartate aminotransferase measurement | Alanine aminotransferase measurement
Item
ast and alt < 4 times upper limit of normal
boolean
C0201899 (UMLS CUI [1])
C0201836 (UMLS CUI [2])
C0201836 (UMLS CUI [2])
Serum total bilirubin measurement
Item
bilirubin < 2.0 mg/dl
boolean
C1278039 (UMLS CUI [1])
Exclusion | Congestive heart failure
Item
no active congestive heart failure
boolean
C2828389 (UMLS CUI [1])
C0018802 (UMLS CUI [2])
C0018802 (UMLS CUI [2])
Exclusion Criteria | Ketoconazole allergy | Dexamethasone allergy | Hydrocortisone allergy | Hypersensitivity Dexamethasone Component | Hypersensitivity Hydrocortisone Component | Hypersensitivity Ketoconazole Component
Item
no allergy to ketoconazole, dexamethasone, hydrocortisone, or to one of the components of dexamethasone, hydrocortisone, or ketoconazole
boolean
C0680251 (UMLS CUI [1])
C0571275 (UMLS CUI [2])
C0571611 (UMLS CUI [3])
C0571588 (UMLS CUI [4])
C0020517 (UMLS CUI [5,1])
C0011777 (UMLS CUI [5,2])
C1705248 (UMLS CUI [5,3])
C0020517 (UMLS CUI [6,1])
C0020268 (UMLS CUI [6,2])
C1705248 (UMLS CUI [6,3])
C0020517 (UMLS CUI [7,1])
C0022625 (UMLS CUI [7,2])
C1705248 (UMLS CUI [7,3])
C0571275 (UMLS CUI [2])
C0571611 (UMLS CUI [3])
C0571588 (UMLS CUI [4])
C0020517 (UMLS CUI [5,1])
C0011777 (UMLS CUI [5,2])
C1705248 (UMLS CUI [5,3])
C0020517 (UMLS CUI [6,1])
C0020268 (UMLS CUI [6,2])
C1705248 (UMLS CUI [6,3])
C0020517 (UMLS CUI [7,1])
C0022625 (UMLS CUI [7,2])
C1705248 (UMLS CUI [7,3])
Exclusion | Communicable Disease
Item
no active infection
boolean
C2828389 (UMLS CUI [1])
C0009450 (UMLS CUI [2])
C0009450 (UMLS CUI [2])
Exclusion | Glaucoma Uncontrolled
Item
no uncontrolled glaucoma
boolean
C2828389 (UMLS CUI [1])
C0017601 (UMLS CUI [2,1])
C0205318 (UMLS CUI [2,2])
C0017601 (UMLS CUI [2,1])
C0205318 (UMLS CUI [2,2])
Exclusion | Peptic Ulcer
Item
no active peptic ulcer disease
boolean
C2828389 (UMLS CUI [1])
C0030920 (UMLS CUI [2])
C0030920 (UMLS CUI [2])
Exclusion | Diabetic - poor control
Item
no uncontrolled diabetes mellitus
boolean
C2828389 (UMLS CUI [1])
C0421258 (UMLS CUI [2])
C0421258 (UMLS CUI [2])
Fertility Contraceptive methods
Item
fertile patients must use effective contraception during and for 3 months after completion of study therapy
boolean
C0015895 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
C0700589 (UMLS CUI [1,2])
Therapeutic procedure
Item
prior concurrent therapy:
boolean
C0087111 (UMLS CUI [1])
Exclusion | Pharmaceutical Preparations Interaction Investigational Therapy
Item
more than 2 weeks since prior and no concurrent drugs known to interact with study treatment
boolean
C2828389 (UMLS CUI [1])
C0013227 (UMLS CUI [2,1])
C0687133 (UMLS CUI [2,2])
C0949266 (UMLS CUI [2,3])
C0013227 (UMLS CUI [2,1])
C0687133 (UMLS CUI [2,2])
C0949266 (UMLS CUI [2,3])